Penumbra (PEN) EBITDA Margin Growth (1y) (2015 - 2026)
Penumbra (PEN) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 146.00 |
| 10 | Penumbra | 12.78 Bn | 12.12 Bn | 264.94 Mn | -151.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151.00 |
| Mar 31, 2026 | -225.00 |
| Dec 31, 2025 | 181.00 |
| Sep 30, 2025 | 202.00 |
| Jun 30, 2025 | 3,907.00 |
| Mar 31, 2025 | 811.00 |
| Dec 31, 2024 | 125.00 |
| Sep 30, 2024 | 709.00 |
| Jun 30, 2024 | -3,388.00 |
| Mar 31, 2024 | 103.00 |
| Dec 31, 2023 | 1,012.00 |
| Sep 30, 2023 | 212.00 |
| Jun 30, 2023 | 691.00 |
| Mar 31, 2023 | 530.00 |
| Dec 31, 2022 | 2,182.00 |
| Sep 30, 2022 | -208.00 |
| Jun 30, 2022 | -566.00 |
| Mar 31, 2022 | -994.00 |
| Dec 31, 2021 | -1,859.00 |
| Sep 30, 2021 | 1,796.00 |